A case of prolonged COVID‐19 treated with tixagevimab/cilgavimab

por Shimizu, Takahiro, Shirasaki, Hiroki, Okafuji, Kazuhiro, Sawazaki, Aiko, Iwabuchi, Tasuku, Matubayashi, Ryo
Publicado 2023

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL

por Miyazaki, Kana, Sakai, Rika, Iwaki, Noriko, Yamamoto, Go, Murayama, Kayoko, Nishikori, Momoko, Sunami, Kazutaka, Yoshida, Isao, Yano, Hiroki, Takahashi, Naoki, Okamoto, Akinao, Munemoto, Saori, Sawazaki, Aiko, Suehiro, Youko, Fukuhara, Noriko, Wake, Atsushi, Arai, Ayako, Masaki, Yasufumi, Toyama, Kohtaro, Yokoyama, Akihiro, Tsunemine, Hiroko, Hasegawa, Yuichi, Matsumoto, Kenji, Yamada, Tomomi, Nishimura, Yuki, Tamaru, Satoshi, Asano, Naoko, Miyawaki, Kohta, Izutsu, Koji, Kinoshita, Tomohiro, Suzuki, Ritsuro, Ohshima, Koichi, Kato, Koji, Katayama, Naoyuki, Yamaguchi, Motoko
Publicado 2023